AI assistant
UBS Group AG — Audit Report / Information 2019
Oct 22, 2019
998_ffr_2019-10-22_c5badf85-ee63-4907-8113-119b9eab5dab.zip
Audit Report / Information
Open in viewerOpens in your device viewer
6-K 1 6k3q19ubsbaseIIIpillar3.htm 6k3q19ubsbaselIIIpillar3
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
Date: October 22, 2019
UBS Group AG
Commission File Number: 1-36764
UBS AG
Commission File Number: 1-15060
(Registrants' Name)
Bahnhofstrasse 45, Zurich, Switzerland and Aeschenvorstadt 1, Basel, Switzerland
(Address of principal executive offices)
Indicate by check mark whether the registrants file or will file annual reports under cover of Form 20‑F or Form 40-F.
Form 20-F x Form 40-F o
This Form 6-K consists of the Basel III Pillar 3 disclosure for UBS Group AG and significant regulated subsidiaries report as of 22 October 2019, which appears immediately following this page.
30 September 2019 Pillar 3 report
UBS Group and significant regulated subsidiaries and sub-groups
| Table
of contents | | |
| --- | --- | --- |
| Introduction and basis for
preparation | | |
| UBS Group | | |
| 4 | Section
1 | Key metrics |
| 6 | Section
2 | Risk-weighted assets |
| 10 | Section
3 | Going and gone concern
requirements and eligible capital |
| 11 | Section
4 | Leverage ratio |
| 14 | Section
5 | Liquidity coverage ratio |
| Significant regulated
subsidiaries and sub-groups | | |
| 18 | Section
1 | Introduction |
| 18 | Section
2 | UBS AG standalone |
| 22 | Section
3 | UBS Switzerland AG standalone |
| 28 | Section
4 | UBS Europe SE consolidated |
| 29 | Section
5 | UBS Americas Holding LLC consolidated |
Contacts
Switchboards
For all general inquiries www.ubs.com/contact
Zurich +41-44-234 1111 London +44- 207-567 8000 New York +1-212-821 3000 Hong Kong +852-2971 8888 Singapore +65-6495 8000
Investor Relations
UBS’s Investor Relations team supports institutional, professional and retail investors from our offices in Zurich, London, New York and Krakow.
UBS Group AG, Investor Relations P.O. Box, CH-8098 Zurich, Switzerland
www.ubs.com/investors
Zurich +41-44-234 4100 New York +1-212-882 5734
Media Relations
UBS’s Media Relations team supports global media and journalists from our offices in Zurich, London, New York and Hong Kong.
www.ubs.com/media
Zurich +41-44-234 8500 [email protected]
London +44-20-7567 4714 [email protected]
New York +1-212-882 5858 [email protected]
Hong Kong +852-2971 8200 [email protected]
Office of the Group Company Secretary
The Group Company Secretary receives inquiries regarding compensation and related issues addressed to members of the Board of Directors.
UBS Group AG, Office of the Group Company Secretary P.O. Box, CH-8098 Zurich, Switzerland
+41-44-235 6652
Shareholder Services
UBS’s Shareholder Services team, a unit of the Group Company Secretary Office, is responsible for the registration of UBS Group AG registered shares.
UBS Group AG, Shareholder Services P.O. Box, CH-8098 Zurich, Switzerland
+41-44-235 6652
US Transfer Agent
For global registered share-related inquiries in the US.
Computershare Trust Company NA P.O. Box 505000 Louisville, KY 40233-5000, USA
Shareholder online inquiries: www-us.computershare.com/ investor/Contact
Shareholder website: www.computershare.com/investor
Calls from the US +1-866-305-9566 Calls from outside the US +1-781-575-2623 TDD for hearing impaired +1-800-231-5469 TDD for foreign shareholders +1-201-680-6610
Imprint
Publisher: UBS Group AG, Zurich, Switzerland | www.ubs.com Language: English
© UBS 2019. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.
Introduction and basis for preparation
Introduction and basis for preparation
Introduction and basis for preparation
Scope and location of Basel III Pillar 3 disclosures
The Basel Committee on Banking Supervision (BCBS) Basel III capital adequacy framework consists of three complementary pillars. Pillar 1 provides a framework for measuring minimum capital requirements for the credit, market, operational and non-counterparty-related risks faced by banks. Pillar 2 addresses the principles of the supervisory review process, emphasizing the need for a qualitative approach to supervising banks. Pillar 3 requires banks to publish a range of disclosures, mainly covering risk, capital, leverage, liquidity and remuneration.
This report provides Pillar 3 disclosures for UBS Group and prudential key figures and regulatory information for UBS AG standalone, UBS Switzerland AG standalone, UBS Europe SE consolidated and UBS Americas Holding LLC consolidated in the respective sections under “Significant regulated subsidiaries and sub-groups.”
As UBS is considered a systemically relevant bank (SRB) under Swiss banking law, UBS Group AG and UBS AG are required to comply with regulations based on the Basel III framework as applicable to Swiss SRBs on a consolidated basis. Capital and other regulatory information as of 30 September 2019 for UBS Group AG consolidated is provided in the “Capital management” section of our third quarter 2019 report and for UBS AG consolidated in the “Capital management” section of the UBS AG third quarter 2019 report available under “Quarterly reporting” at www.ubs.com/investors .
Local regulators may also require the publication of Pillar 3 information at a subsidiary or sub-group level. Where applicable, these local disclosures are provided under “Holding company and significant regulated subsidiaries and sub-groups” at www.ubs.com/investors.
Significant BCBS and FINMA capital adequacy, liquidity and funding, and related disclosure requirements
This Pillar 3 report has been prepared in accordance with FINMA Pillar 3 disclosure requirements (FINMA Circular 2016/1, “Disclosure – banks”) as revised on 16 July 2018, the underlying BCBS guidance “Revised Pillar 3 disclosure requirements” issued in January 2015, the “Frequently asked questions on the revised Pillar 3 disclosure requirements” issued in August 2016, the “Pillar 3 disclosure requirements – consolidated and enhanced framework” issued in March 2017 and the subsequent “Technical Amendment – Pillar 3 disclosure requirements – regulatory treatment of accounting provisions” issued in August 2018.
Frequency and comparability of Pillar 3 disclosures
FINMA has specified the reporting frequency for each disclosure, as outlined in the table on pages 5 and 6 of our 31 December 2018 Pillar 3 report available under “Pillar 3 disclosures” at www.ubs.com/investors .
In line with the FINMA-specified disclosure frequency and requirements for disclosure with regard to comparative periods, we provide quantitative comparative information as of 30 June 2019 for disclosures required on a quarterly basis. Where specifically required by FINMA and / or BCBS, we disclose comparative information for additional reporting dates.
2
UBS Group AG
UBS Group
Section 1 Key metrics
Key metrics of the third quarter of 2019
The KM1 and KM2 tables below are based on Basel Committee on Banking Supervision (BCBS) Basel III phase-in rules. The KM2 table includes a reference to the total loss-absorbing capacity (TLAC) term sheet, published by the Financial Stability Board (FSB). The website of the FSB provides this term sheet, at www.fsb.org/2015/11/total-loss-absorbing-capacity-tlac-principles-and-term-sheet .
During the third quarter of 2019, our common equity tier 1 (CET1) capital decreased by USD 0.3 billion to USD 34.7 billion, mainly as a result of accruals for capital returns to shareholders, share repurchases under our share repurchase program, foreign currency translation effects, current tax expense and increases in pension liabilities of non-Swiss pension plans, partly offset by operating profit before tax. Our tier 1 capital increased by USD 0.7 billion to USD 50.7 billion, primarily reflecting two separate issuances of high-trigger loss-absorbing AT1 instruments of AUD 700 million and SGD 750 million, respectively.
® Refer to “UBS shares” in the “Capital management” section of our third quarter 2019 report for more information about the share repurchase program
The TLAC available as of 30 September 2019 included CET1 capital, additional tier 1 and tier 2 capital instruments eligible under the TLAC framework, and non-regulatory capital elements of TLAC. Under the Swiss systemically relevant bank (SRB) framework, including transitional arrangements, TLAC excludes 45% of the gross unrealized gains on debt instruments measured at fair value through other comprehensive income for accounting purposes, which for regulatory capital purposes is measured at the lower of cost or market value. This amount was negligible as of 30 September 2019, but is included as available TLAC in the KM2 table below.
Risk-weighted assets (RWA) increased by USD 2.5 billion to USD 264.6 billion, mainly due to an increase in credit risk RWA, partly offset by a decrease in market risk RWA. Leverage ratio exposure decreased by USD 9 billion during the quarter, predominantly driven by on-balance sheet exposures. High-quality liquid assets decreased by USD 8.3 billion, primarily driven by a reduction of cash at central banks reflecting higher average funding consumption by the business divisions and reductions in the level of issued debt.
4
| KM1: Key metrics | ||||||
|---|---|---|---|---|---|---|
| USD million, except where | ||||||
| indicated | ||||||
| 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 | 30.9.18 3 | ||
| Available capital (amounts) 1 | ||||||
| 1 | Common equity tier 1 (CET1) | 34,673 | 34,948 | 34,658 | 34,119 | 34,816 |
| 1a | Fully loaded ECL accounting model | 34,635 | 34,904 | 34,613 | 34,071 | 34,816 |
| 2 | Tier 1 | 50,702 | 49,993 | 49,436 | 46,279 | 45,972 |
| 2a | Fully loaded ECL accounting model Tier 1 | 50,664 | 49,949 | 49,391 | 46,231 | 45,972 |
| 3 | Total capital | 56,396 | 56,345 | 56,148 | 52,981 | 52,637 |
| 3a | Fully loaded ECL accounting model total capital | 56,358 | 56,302 | 56,103 | 52,933 | 52,637 |
| Risk-weighted assets | ||||||
| (amounts) | ||||||
| 4 | Total risk-weighted assets (RWA) | 264,626 | 262,135 | 267,556 | 263,747 | 257,041 |
| 4a | Minimum capital requirement 2 | 21,170 | 20,971 | 21,404 | 21,100 | 20,563 |
| 4b | Total risk-weighted assets (pre-floor) | 264,626 | 262,135 | 267,556 | 263,747 | 257,041 |
| Risk-based capital ratios as | ||||||
| a percentage of RWA 1 | ||||||
| 5 | Common equity tier 1 ratio (%) | 13.10 | 13.33 | 12.95 | 12.94 | 13.55 |
| 5a | Fully loaded ECL accounting model Common equity tier 1 (%) | 13.09 | 13.32 | 12.94 | 12.92 | 13.55 |
| 6 | Tier 1 ratio (%) | 19.16 | 19.07 | 18.48 | 17.55 | 17.89 |
| 6a | Fully loaded ECL accounting model Tier 1 ratio (%) | 19.15 | 19.05 | 18.46 | 17.53 | 17.89 |
| 7 | Total capital ratio (%) | 21.31 | 21.49 | 20.99 | 20.09 | 20.48 |
| 7a | Fully loaded ECL accounting model total capital ratio (%) | 21.30 | 21.48 | 20.97 | 20.07 | 20.48 |
| Additional CET1 buffer | ||||||
| requirements as a percentage of RWA | ||||||
| 8 | Capital conservation buffer requirement (2.5% from 2019) (%) | 2.50 | 2.50 | 2.50 | 1.88 | 1.88 |
| 9 | Countercyclical buffer requirement (%) | 0.10 | 0.09 | 0.10 | 0.08 | 0.05 |
| 9a | Additional countercyclical buffer for Swiss mortgage loans (%) | 0.21 | 0.22 | 0.21 | 0.21 | 0.21 |
| 10 | Bank G-SIB and/or D-SIB additional requirements (%) | 1.00 | 1.00 | 1.00 | 0.75 | 0.75 |
| 11 | Total of bank CET1-specific buffer requirements (%) 1 | 3.60 | 3.59 | 3.60 | 2.71 | 2.68 |
| 12 | CET1 available after meeting the bank’s minimum capital | |||||
| requirements (%) 1 | 8.60 | 8.83 | 8.45 | 8.44 | 9.05 | |
| Basel III leverage ratio | ||||||
| 13 | Total Basel III leverage ratio exposure measure | 901,914 | 911,379 | 910,993 | 904,598 | 915,066 |
| 14 | Basel III leverage ratio (%) 1 | 5.62 | 5.49 | 5.43 | 5.12 | 5.02 |
| 14a | Fully loaded ECL accounting model Basel III leverage ratio (%) 1 | 5.62 | 5.48 | 5.42 | 5.11 | 5.02 |
| Liquidity coverage ratio | ||||||
| 15 | Total HQLA | 167,916 | 176,173 | 186,038 | 173,389 | 176,594 |
| 16 | Total net cash outflow | 122,025 | 121,314 | 121,521 | 127,352 | 130,750 |
| 17 | LCR ratio (%) | 138 | 145 | 153 | 136 | 135 |
| 1 Based on BCBS Basel III phase-in rules. 2 Calculated as 8% | ||||||
| of total RWA, based on total capital minimum requirements, excluding CET1 | ||||||
| buffer requirements. 3 In line with the change of the presentation | ||||||
| currency of UBS Group AG’s and UBS AG’s consolidated and standalone financial | ||||||
| statements from Swiss francs to US dollars in October 2018, prior-period | ||||||
| disclosures were translated to US dollars at the respective spot rates | ||||||
| prevailing on the relevant reporting dates. |
| KM2: Key metrics – TLAC
requirements (at resolution group level) 1 | | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| USD million, except where
indicated | | | | | | |
| | | 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 | 30.9.18 2 |
| 1 | Total loss-absorbing capacity (TLAC) available | 88,197 | 87,388 | 87,477 | 83,740 | 81,711 |
| 1a | Fully loaded ECL accounting model TLAC available | 88,159 | 87,344 | 87,433 | 83,692 | 81,711 |
| 2 | Total RWA at the level of the resolution group | 264,626 | 262,135 | 267,556 | 263,747 | 257,041 |
| 3 | TLAC as a percentage of RWA (%) | 33.33 | 33.34 | 32.69 | 31.75 | 31.79 |
| 3a | Fully loaded ECL accounting model TLAC as a percentage of fully
loaded ECL accounting model RWA (%) | 33.31 | 33.32 | 32.68 | 31.73 | 31.79 |
| 4 | Leverage ratio exposure measure at the level of the resolution
group | 901,914 | 911,379 | 910,993 | 904,598 | 915,066 |
| 5 | TLAC as a percentage of leverage ratio exposure measure (%) | 9.78 | 9.59 | 9.60 | 9.26 | 8.93 |
| 5a | Fully loaded ECL accounting model TLAC as a percentage of fully
loaded ECL accounting model Leverage exposure measure (%) | 9.77 | 9.58 | 9.60 | 9.25 | 8.93 |
| 6a | Does the subordination exemption in the antepenultimate
paragraph of Section 11 of the FSB TLAC Term Sheet apply? | No | | | | |
| 6b | Does the subordination exemption in the penultimate paragraph of
Section 11 of the FSB TLAC Term Sheet apply? | No | | | | |
| 6c | If the capped subordination exemption applies, the amount of
funding issued that ranks pari passu with excluded liabilities and that is
recognized as external TLAC, divided by funding issued that ranks pari passu
with excluded liabilities and that would be recognized as external TLAC if no
cap was applied (%) | N/A – Refer to our response to 6b. | | | | |
| 1 Resolution group level is defined as the UBS Group AG
consolidated level. 2 In line with the change of the presentation currency
of UBS Group AG’s and UBS AG’s consolidated and standalone financial
statements from Swiss francs to US dollars in October 2018, prior-period
disclosures were translated to US dollars at the respective spot rates
prevailing on the relevant reporting dates. | | | | | | |
5
UBS Group
Section 2 Risk-weighted assets
Our approach to measuring risk exposure and risk-weighted assets
Depending on the purpose, the measurement of risk exposure that we apply may differ. Exposures may be measured for financial accounting purposes under International Financial Reporting Standards (IFRS), for deriving our regulatory capital requirements or for internal risk management and control purposes. Our Pillar 3 disclosures are generally based on measures of risk exposure used to derive the regulatory capital required under Pillar 1. Our risk-weighted assets (RWA) are calculated according to the Basel Committee on Banking Supervision (BCBS) Basel III framework, as implemented by the Swiss Capital Adequacy Ordinance issued by the Swiss Federal Council and by the associated circulars issued by the Swiss Financial Market Supervisory Authority (FINMA).
For information about the measurement of risk exposures and RWA, refer to pages 9–12 of our 31 December 2018 Pillar 3 report available under “Pillar 3 disclosures” at www.ubs.com/investors .
RWA development in the third quarter of 2019
The OV1 table below provides an overview of our risk-weighted assets (RWA) and the related minimum capital requirements by risk type. The FINMA template includes rows that are currently not applicable to UBS and therefore have been left empty.
During the third quarter of 2019, RWA increased by USD 2.5 billion to USD 264.6 billion, mainly due to an increase of USD 5.0 billion in credit risk RWA, partly offset by a decrease of USD 1.8 billion in market risk RWA.
The flow tables for credit risk, counterparty credit risk and market risk RWA in the respective sections of this report provide further details regarding the movements in RWA in the third quarter of 2019. More information about capital management and RWA, including details of movements in RWA during the third quarter of 2019, is provided on pages 55 – 56 of our third quarter 2019 report, available under “Quarterly reporting” at www.ubs.com/investors .
6
| OV1: Overview of RWA — USD million | RWA | Minimum capital requirements 1 | ||
|---|---|---|---|---|
| 30.9.19 | 30.6.19 | 30.9.19 | ||
| 1 | Credit risk (excluding | |||
| counterparty credit risk) | 119,969 | 114,991 | 9,598 | |
| 2 | of which: standardized | |||
| approach (SA) 2 | 27,786 | 28,287 | 2,223 | |
| 3 | of which: foundation | |||
| internal ratings-based (F-IRB) approach | ||||
| 4 | of which: supervisory | |||
| slotting approach | ||||
| 5 | of which: advanced internal | |||
| ratings-based (A-IRB) approach | 92,183 | 86,703 | 7,375 | |
| 6 | Counterparty credit risk 3 | 37,259 | 37,487 | 2,981 |
| 7 | of which: SA for | |||
| counterparty credit risk (SA-CCR) 4 | 5,962 | 5,793 | 477 | |
| 8 | of which: internal model | |||
| method (IMM) | 19,309 | 20,133 | 1,545 | |
| 8a | of which: value-at-risk | |||
| (VaR) | 5,426 | 5,453 | 434 | |
| 9 | of which: other CCR | 6,561 | 6,107 | 525 |
| 10 | Credit valuation adjustment | |||
| (CVA) | 2,458 | 2,553 | 197 | |
| 11 | Equity positions under the simple | |||
| risk weight approach 5 | 3,248 | 3,302 | 260 | |
| 12 | Equity investments in funds | |||
| – look-through approach 6 | ||||
| 13 | Equity investments in funds | |||
| – mandate-based approach 6 | ||||
| 14 | Equity investments in funds | |||
| – fall-back approach 6 | ||||
| 15 | Settlement risk | 347 | 415 | 28 |
| 16 | Securitization exposures in | |||
| banking book | 656 | 664 | 52 | |
| 17 | of which: securitization | |||
| internal ratings-based approach (SEC-IRBA) | ||||
| 18 | of which: securitization | |||
| external ratings-based approach (SEC-ERBA) including internal assessment approach | ||||
| (IAA) | 647 | 657 | 52 | |
| 19 | of which: securitization | |||
| standardized approach (SEC-SA) | 8 | 7 | 1 | |
| 20 | Market risk | 9,207 | 10,977 | 737 |
| 21 | of which: standardized | |||
| approach (SA) | 492 | 452 | 39 | |
| 22 | of which: internal model | |||
| approaches (IMA) | 8,714 | 10,526 | 697 | |
| 23 | Capital charge for switch | |||
| between trading book and banking book | ||||
| 24 | Operational risk | 80,345 | 80,345 | 6,428 |
| 25 | Amounts below thresholds for | |||
| deduction (250% risk weight) 7 | 11,138 | 11,402 | 891 | |
| 26 | Floor adjustment 8 | 0 | 0 | 0 |
| 27 | Total | 264,626 | 262,135 | 21,170 |
| 1 Calculated based on 8% of RWA. 2 Includes | ||||
| non-counterparty-related risk not subject to the threshold deduction | ||||
| treatment (30 September 2019: RWA USD 12,678 million; 30 June 2019: RWA USD | ||||
| 12,912 million). Non-counterparty-related risk (30 September 2019: RWA USD | ||||
| 8,699 million; 30 June 2019: RWA USD 8,853 million) which is subject to the | ||||
| threshold deduction treatment is reported in line 25 “Amounts below | ||||
| thresholds for deduction (250% risk weight).” 3 Excludes settlement risk, | ||||
| which is separately reported in line 15 “Settlement risk.” Includes RWA with | ||||
| central counterparties. A new regulation for the calculation of RWA for | ||||
| exposure to central counterparties will be implemented by 1 January 2020. The | ||||
| split between the subcomponents of counterparty credit risk refers to the | ||||
| calculation of the exposure measure. 4 Calculated in accordance with | ||||
| the current exposure method (CEM) until SA-CCR is implemented by | ||||
| 1 January 2020. 5 Includes investments in funds. Items subject to | ||||
| threshold deduction treatments that do not exceed their respective threshold | ||||
| are risk weighted at 250% (30 September 2019: RWA USD 2,439 million; 30 June | ||||
| 2019: RWA USD 2,548 million) and are separately included in line 25 “Amounts | ||||
| below thresholds for deduction (250% risk weight).” 6 A new regulation for | ||||
| the calculation of RWA for investments in funds will be implemented by | ||||
| 1 January 2020. 7 Includes items subject to threshold deduction | ||||
| treatments that do not exceed their respective threshold and risk weighted at | ||||
| 250%. Items subject to threshold deduction treatments are significant | ||||
| investments in common shares of non-consolidated financial institutions | ||||
| (banks, insurance and other financial entities) and deferred tax assets | ||||
| arising from temporary differences, both of which are measured against their | ||||
| respective threshold. 8 No floor effect, as 80% of our Basel I RWA | ||||
| including the RWA equivalent of the Basel I capital deductions does not | ||||
| exceed our Basel III RWA including the RWA equivalent of the Basel III | ||||
| capital deductions. For the status of the finalization of the Basel III | ||||
| capital framework, refer to the “Regulatory and legal developments” section | ||||
| of our Annual Report 2018, available under “Annual reporting” at | ||||
| www.ubs.com/investors, which outlines how the proposed floor calculation | ||||
| would differ in significant aspects from the current approach. |
7
UBS Group
The CR8 table below provides a breakdown of the credit risk RWA movements in the third quarter of 2019 across movement categories defined by the Basel Committee on Banking Supervision (BCBS). These categories are described on page 45 of our 31 December 2018 Pillar 3 report available under “Pillar 3 disclosures” at www.ubs.com/investors .
Credit risk RWA development in the third quarter of 2019
Credit risk RWA under the advanced internal ratings-based (A-IRB) approach increased by USD 5.5 billion to USD 92.2 billion as of 30 September 2019.
The RWA increase from asset size movements of USD 5.8 billion was predominantly driven by increases in traded loans, term loans exposures and unutilized credit facilities in the Investment Bank’s Corporate Client Solutions business.
The increase in RWA from model updates of USD 0.9 billion was mainly driven by the continued phasing-in of RWA increases related to probability of default (PD) and loss given default (LGD) changes from the implementation of revised models for Swiss residential mortgages, which resulted in RWA increases of USD 0.4 billion in Personal & Corporate Banking and USD 0.1 billion in Global Wealth Management. In addition, a change of the credit conversion factor from 5% to 10% for zero-balance securities-backed lending and margin loans exposures increased RWA in Global Wealth Management by USD 0.4 billion.
The aforementioned increases were partly offset by a USD 1.3 billion decrease in RWA due to currency effects. p
| CR8: RWA flow statements of
credit risk exposures under IRB — USD million | | RWA |
| --- | --- | --- |
| 1 | RWA as of 30.6.19 | 86,703 |
| 2 | Asset size | 5,830 |
| 3 | Asset quality | 472 |
| 4 | Model updates | 861 |
| 5 | Methodology and policy | 0 |
| 6 | Acquisitions and disposals | 0 |
| 7 | Foreign exchange movements | (1,313) |
| 8 | Other | (370) |
| 9 | RWA as of 30.9.19 | 92,183 |
Counterparty credit risk RWA development in the third quarter of 2019
Counterparty credit risk RWA under the internal model method (IMM) decreased by USD 0.8 billion to USD 19.3 billion during the third quarter of 2019, primarily due to lower notional amounts in the Investment Bank’s Foreign Exchange, Rates and Credit business and trade expiries in its Equities business. p
| CCR7: RWA flow statements of
CCR exposures under internal model method (IMM) and value-at-risk (VaR) | | | | |
| --- | --- | --- | --- | --- |
| | | For the quarter ended 30.9.19 | | |
| | | Derivatives | SFTs | Total |
| USD million | | Subject to IMM | Subject to VaR | |
| 1 | RWA as of 30.6.19 | 20,133 | 5,453 | 25,587 |
| 2 | Asset size | (648) | 106 | (543) |
| 3 | Credit quality of counterparties | (5) | (80) | (85) |
| 4 | Model updates | 0 | 0 | 0 |
| 5 | Methodology and policy | 0 | 0 | 0 |
| 5a | of which: regulatory add-ons | | | |
| 6 | Acquisitions and disposals | 0 | 0 | 0 |
| 7 | Foreign exchange movements | (170) | (53) | (223) |
| 8 | Other | 0 | 0 | 0 |
| 9 | RWA as of 30.9.19 | 19,309 | 5,426 | 24,736 |
8
Market risk RWA development in the third quarter of 2019
The three main components that contribute to market risk RWA are Value-at-risk (VaR), stressed value-at-risk (SVaR) and incremental risk charge (IRC). VaR and SVaR components include the RWA charge for risks-not-in-VaR.
The MR2 table below provides a breakdown of the market risk RWA under an internal models approach movement in the third quarter of 2019 across these components, according to the movement categories defined by the Basel Committee on Banking Supervision. These categories are described on page 81 of our 31 December 2018 Pillar 3 report available under “Pillar 3 disclosures” at www.ubs.com/investors .
Market risk RWA decreased by USD 1.8 billion to USD 8.7 billion in the third quarter of 2019, mainly driven by model updates reflecting changes to the VaR model parameters following our periodic review of VaR model parameters and, to a lesser extent, by regulatory add-ons which reflect updates from the monthly risks-not-in-VaR assessment.
From 30 June 2019 onward, the comprehensive risk measure (CRM)-based capital requirement has no longer been applicable to us, as we no longer hold eligible correlation trading positions.
The VaR multiplier remained unchanged, at 3.0, compared with the second quarter of 2019.
| MR2: RWA flow statements of
market risk exposures under an internal models approach 1 — USD million | | VaR | Stressed VaR | IRC | Total RWA |
| --- | --- | --- | --- | --- | --- |
| 1 | RWA as of 30.6.19 | 2,561 | 6,441 | 1,524 | 10,526 |
| 1a | Regulatory adjustment | (1,874) | (4,591) | (212) | (6,677) |
| 1b | RWA at previous quarter-end (end of day) | 687 | 1,850 | 1,312 | 3,849 |
| 2 | Movement in risk levels | 987 | 1,295 | (61) | 2,222 |
| 3 | Model updates / changes | (909) | (1,749) | 136 | (2,522) |
| 4 | Methodology and policy | 0 | 0 | 0 | 0 |
| 5 | Acquisitions and disposals | 0 | 0 | 0 | 0 |
| 6 | Foreign exchange movements | 0 | 0 | 0 | 0 |
| 7 | Other | (49) | (127) | 0 | (176) |
| 8a | RWA at the end of the reporting period (end of day) | 716 | 1,270 | 1,388 | 3,374 |
| 8b | Regulatory adjustment | 1,481 | 3,837 | 23 | 5,341 |
| 8c | RWA as of 30.9.19 | 2,197 | 5,107 | 1,411 | 8,714 |
| 1 Components that describe movements in RWA are presented in
italics. | | | | | |
9
UBS Group
Section 3 Going and gone concern requirements and eligible capital
The table below provides details of the Swiss systemically relevant bank (SRB) going and gone concern capital requirements as required by FINMA. More information about capital management is provided on pages 49–58 of our third quarter 2019 report available under “Quarterly reporting” at www.ubs.com/investors .
| Swiss SRB going and gone
concern requirements and information | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | Swiss SRB, including transitional arrangements | | | | Swiss SRB as of 1.1.20 | | | |
| As of 30.9.19 | RWA | | LRD | | RWA | | LRD | |
| USD million, except where
indicated | in % | | in % | | in % | | in % | |
| Required going concern
capital | | | | | | | | |
| Total going concern capital | 13.89 | 36,748 | 4.50 | 40,586 | 14.61 1 | 38,654 | 5.00 1 | 45,096 |
| Common equity tier 1 capital | 9.99 | 26,428 | 3.20 | 28,861 | 10.31 | 27,275 | 3.50 | 31,567 |
| of which: minimum capital | 4.90 | 12,967 | 1.70 | 15,333 | 4.50 | 11,908 | 1.50 | 13,529 |
| of which: buffer capital | 4.78 | 12,649 | 1.50 | 13,529 | 5.50 | 14,554 | 2.00 | 18,038 |
| of which: countercyclical
buffer | 0.31 | 812 | | | 0.31 | 812 | | |
| Maximum additional tier 1
capital | 3.90 | 10,320 | 1.30 | 11,725 | 4.30 | 11,379 | 1.50 | 13,529 |
| of which: additional tier 1
capital | 3.10 | 8,203 | 1.30 | 11,725 | 3.50 | 9,262 | 1.50 | 13,529 |
| of which: additional tier 1
buffer capital | 0.80 | 2,117 | | | 0.80 | 2,117 | | |
| Eligible going concern
capital | | | | | | | | |
| Total going concern capital | 21.10 | 55,843 | 6.19 | 55,843 | 19.16 | 50,702 | 5.62 | 50,702 |
| Common equity tier 1 capital | 13.10 | 34,673 | 3.84 | 34,673 | 13.10 | 34,673 | 3.84 | 34,673 |
| Total loss-absorbing
additional tier 1 capital | 8.00 | 21,169 | 2.35 | 21,169 | 6.06 | 16,029 | 1.78 | 16,029 |
| of which: high-trigger
loss-absorbing additional tier 1 capital | 5.15 | 13,625 | 1.51 | 13,625 | 5.15 | 13,625 | 1.51 | 13,625 |
| of which: low-trigger
loss-absorbing additional tier 1 capital 2 | 0.91 | 2,404 | 0.27 | 2,404 | 0.91 | 2,404 | 0.27 | 2,404 |
| of which: low-trigger
loss-absorbing tier 2 capital 3 | 1.94 | 5,140 | 0.57 | 5,140 | | | | |
| Required gone concern
capital | | | | | | | | |
| Total gone concern
loss-absorbing capacity | 9.63 | 25,478 | 3.32 | 29,944 | 10.57 | 27,972 | 3.77 | 33,993 |
| of which: base requirement | 10.52 | 27,839 | 3.63 | 32,694 | 12.86 | 34,031 | 4.50 | 40,586 |
| of which: additional
requirement for market share and LRD | 1.08 | 2,858 | 0.38 | 3,382 | 1.44 | 3,811 | 0.50 | 4,510 |
| of which: applicable
reduction on requirements | (1.97) | (5,218) | (0.68) | (6,133) | (3.73) | (9,870) | (1.23) | (11,103) |
| of which: rebate granted
(equivalent to 42.5% of maximum rebate) 4 | (1.97) | (5,218) | (0.68) | (6,133) | (2.43) | (6,433) | (0.85) | (7,666) |
| of which: reduction for
usage of low-trigger tier 2 capital instruments | | | | | (1.30) | (3,437) | (0.38) | (3,437) |
| Eligible gone concern
capital | | | | | | | | |
| Total gone concern
loss-absorbing capacity | 12.22 | 32,336 | 3.59 | 32,336 | 14.16 | 37,476 | 4.16 | 37,476 |
| Total tier 2 capital | 0.86 | 2,267 | 0.25 | 2,267 | 2.80 | 7,407 | 0.82 | 7,407 |
| of which: low-trigger
loss-absorbing tier 2 capital | 0.65 | 1,733 | 0.19 | 1,733 | 2.60 | 6,873 | 0.76 | 6,873 |
| of which: non-Basel
III-compliant tier 2 capital | 0.20 | 534 | 0.06 | 534 | 0.20 | 534 | 0.06 | 534 |
| TLAC-eligible senior
unsecured debt | 11.36 | 30,069 | 3.33 | 30,069 | 11.36 | 30,069 | 3.33 | 30,069 |
| Total loss-absorbing
capacity | | | | | | | | |
| Required total
loss-absorbing capacity | 23.51 | 62,227 | 7.82 | 70,530 | 25.18 | 66,626 | 8.77 | 79,089 |
| Eligible total
loss-absorbing capacity | 33.32 | 88,178 | 9.78 | 88,178 | 33.32 | 88,178 | 9.78 | 88,178 |
| Risk-weighted assets /
leverage ratio denominator | | | | | | | | |
| Risk-weighted assets | 264,626 | | | | 264,626 | | | |
| Leverage ratio denominator | | | 901,914 | | | | 901,914 | |
| 1 Includes applicable add-ons of 1.44% for RWA and 0.5% for
LRD. 2 Includes outstanding low-trigger loss-absorbing additional tier 1
(AT1) capital instruments, which are available under the transitional rules
of the Swiss SRB framework to meet the going concern requirements until their
first call date, even if the first call date is after 31 December 2019. As of
their first call date, these instruments are eligible to meet the gone
concern requirements. 3 Includes outstanding low-trigger
loss-absorbing tier 2 capital instruments, which are available under the
transitional rules of the Swiss SRB framework to meet the going concern
requirements until the earlier of (i) their maturity or first call date or
(ii) 31 December 2019, and to meet gone concern requirements thereafter.
Outstanding low-trigger loss-absorbing tier 2 capital instruments are subject
to amortization starting five years prior to their maturity, with the
amortized portion qualifying as gone concern loss-absorbing capacity.
Instruments available to meet gone concern requirements are eligible until
one year before maturity, with a haircut of 50% applied in the last year of
eligibility. 4 Based on the actions we completed up to December 2018 to
improve resolvability, FINMA granted a rebate on the gone concern requirement
of 42.5% of the maximum rebate in the third quarter of 2019 as compared with
40% in the previous quarter. | | | | | | | | |
10
Section 4 Leverage ratio
BCBS Basel III leverage ratio
The Basel Committee on Banking Supervision (BCBS) leverage ratio is calculated by dividing the period-end tier 1 capital by the period-end leverage ratio denominator (LRD). The LRD consists of IFRS on-balance sheet assets and off-balance sheet items. Derivative exposures are adjusted for a number of items, including replacement value and eligible cash variation margin netting, the current exposure method add-on and net notional amounts for written credit derivatives. The LRD also includes an additional charge for counterparty credit risk related to securities financing transactions (SFTs).
The table on this page shows the difference between total IFRS assets per IFRS consolidation scope and the BCBS total on-balance sheet exposures. Those exposures are the starting point for calculating the BCBS LRD, as shown in the LR2 table below. The difference is due to the application of the regulatory scope of consolidation for the purpose of the BCBS calculation. In addition, carrying values for derivative financial instruments and SFTs are deducted from IFRS total assets. They are measured differently under BCBS leverage ratio rules and are therefore added back in separate exposure line items in the LR2 table.
As of 30 September 2019, our BCBS Basel III leverage ratio was 5.6% and our BCBS Basel III LRD was USD 902 billion.
Difference between the Swiss SRB and BCBS leverage ratio
The LRD is the same under Swiss SRB and BCBS rules. However, there is a difference in the capital numerator between the two frameworks. Under BCBS rules only common equity tier 1 and additional tier 1 capital are included in the numerator. Under Swiss SRB rules we are required to meet going as well as gone concern leverage ratio requirements. Therefore, depending on the requirement, the numerator includes tier 1 capital instruments, tier 2 capital instruments and / or total loss-absorbing capacity (TLAC)-eligible senior unsecured debt.
| Reconciliation of IFRS total
assets to BCBS Basel III total on-balance sheet exposures excluding
derivatives and securities financing transactions — USD million | 30.9.19 | 30.6.19 |
| --- | --- | --- |
| On-balance sheet exposures | | |
| IFRS total assets | 973,118 | 968,727 |
| Adjustment for investments in banking, financial, insurance or
commercial entities that are consolidated for accounting purposes but outside
the scope of regulatory consolidation | (25,850) | (25,625) |
| Adjustment for investments in banking, financial, insurance or
commercial entities that are outside the scope of consolidation for
accounting purposes but consolidated for regulatory purposes | 0 | 0 |
| Adjustment for fiduciary assets recognized on the balance sheet
pursuant to the operative accounting framework but excluded from the leverage
ratio exposure measure | 0 | 0 |
| Less carrying value of derivative financial instruments in IFRS
total assets 1 | (159,917) | (145,470) |
| Less carrying value of securities financing transactions in IFRS
total assets 2 | (119,727) | (120,008) |
| Adjustments to accounting values | 0 | 0 |
| On-balance sheet items
excluding derivatives and securities financing transactions, but including
collateral | 667,624 | 677,624 |
| Asset amounts deducted in determining BCBS Basel III tier 1
capital | (15,562) | (13,461) |
| Total on-balance sheet
exposures (excluding derivatives and securities financing transactions) | 652,062 | 664,164 |
| 1 Consists of derivative financial instruments and cash
collateral receivables on derivative instruments in accordance with the
regulatory scope of consolidation. 2 Consists of receivables from
securities financing transactions, margin loans, prime brokerage receivables
and financial assets at fair value not held for trading related to securities
financing transactions in accordance with the regulatory scope of
consolidation. | | |
11
UBS Group
| LR2: BCBS Basel III leverage ratio common disclosure — USD million, except where
indicated | | 30.9.19 | 30.6.19 |
| --- | --- | --- | --- |
| | On-balance sheet exposures | | |
| 1 | On-balance sheet items excluding derivatives and SFTs, but
including collateral | 667,624 | 677,624 |
| 2 | (Asset amounts deducted in determining Basel III tier 1 capital) | (15,562) | (13,461) |
| 3 | Total on-balance sheet
exposures (excluding derivatives and SFTs) | 652,062 | 664,164 |
| | Derivative exposures | | |
| 4 | Replacement cost associated with all derivatives transactions
(i.e., net of eligible cash variation margin) | 42,484 | 39,849 |
| 5 | Add-on amounts for PFE associated with all derivatives
transactions | 84,565 | 84,806 |
| 6 | Gross-up for derivatives collateral provided where deducted from
the balance sheet assets pursuant to the operative accounting framework | 0 | 0 |
| 7 | (Deductions of receivables assets for cash variation margin
provided in derivatives transactions) | (15,236) | (14,218) |
| 8 | (Exempted CCP leg of client-cleared trade exposures) | (17,895) | (19,289) |
| 9 | Adjusted effective notional amount of all written credit
derivatives 1 | 70,968 | 71,554 |
| 10 | (Adjusted effective notional offsets and add-on deductions for
written credit derivatives) 2 | (69,236) | (69,663) |
| 11 | Total derivative exposures | 95,651 | 93,039 |
| | Securities financing
transaction exposures | | |
| 12 | Gross SFT assets (with no recognition of netting), after
adjusting for sale accounting transactions | 240,069 | 221,683 |
| 13 | (Netted amounts of cash payables and cash receivables of gross
SFT assets) | (120,342) | (101,676) |
| 14 | CCR exposure for SFT assets | 9,260 | 8,672 |
| 15 | Agent transaction exposures | 0 | 0 |
| 16 | Total securities financing transaction
exposures | 128,987 | 128,680 |
| | Other off-balance sheet
exposures | | |
| 17 | Off-balance sheet exposure at gross notional amount | 81,600 | 73,852 |
| 18 | (Adjustments for conversion to credit equivalent amounts) | (56,386) | (48,354) |
| 19 | Total off-balance sheet
items | 25,214 | 25,497 |
| | Total exposures (leverage
ratio denominator) | 901,914 | 911,379 |
| | Capital and total exposures
(leverage ratio denominator) | | |
| 20 | Tier 1 capital | 50,702 | 49,993 |
| 21 | Total exposures (leverage
ratio denominator) | 901,914 | 911,379 |
| | Leverage ratio | | |
| 22 | Basel III leverage ratio (%) | 5.6 | 5.5 |
| 1 Includes protection sold, including agency transactions. 2
Protection sold can be offset with protection bought on the same underlying
reference entity, provided that the conditions according to the Basel III
leverage ratio framework and disclosure requirements are met. | | | |
12
LRD decreased by USD 9 billion to USD 902 billion in the third quarter of 2019, mainly driven by a decrease of USD 13 billion from currency effects, partly offset by a USD 4 billion increase in asset size and other movements.
| LR1: BCBS Basel III leverage
ratio summary comparison — USD million | | 30.9.19 | 30.6.19 |
| --- | --- | --- | --- |
| 1 | Total consolidated assets as per published financial statements | 973,118 | 968,727 |
| 2 | Adjustment for investments in banking, financial, insurance or
commercial entities that are consolidated for accounting purposes but outside
the scope of regulatory consolidation 1 | (41,412) | (39,085) |
| 3 | Adjustment for fiduciary assets recognized on the balance sheet
pursuant to the operative accounting framework but excluded from the leverage
ratio exposure measure | 0 | 0 |
| 4 | Adjustments for derivative financial instruments | (64,266) | (52,432) |
| 5 | Adjustment for securities financing transactions (i.e., repos
and similar secured lending) | 9,260 | 8,672 |
| 6 | Adjustment for off-balance sheet items (i.e., conversion to
credit equivalent amounts of off-balance sheet exposures) | 25,214 | 25,497 |
| 7 | Other adjustments | 0 | 0 |
| 8 | Leverage ratio exposure
(leverage ratio denominator) | 901,914 | 911,379 |
| 1 This item includes assets that are deducted from tier 1
capital. | | | |
| BCBS Basel III leverage ratio — USD million, except where
indicated | 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 |
| --- | --- | --- | --- | --- |
| Total tier 1 capital | 50,702 | 49,993 | 49,436 | 46,279 |
| BCBS total exposures (leverage ratio denominator) | 901,914 | 911,379 | 910,993 | 904,598 |
| BCBS Basel III leverage
ratio (%) | 5.6 | 5.5 | 5.4 | 5.1 |
13
UBS Group
Section 5 Liquidity coverage ratio
LIQ1: Liquidity risk management
We monitor the liquidity coverage ratio (LCR) in all significant currencies in order to manage any currency mismatch between high-quality liquid assets (HQLA) and the net expected cash outflows in times of stress. For information about the concentration of funding sources, refer to the “Funding by product and currency” table in the “Treasury management” section of our third quarter 2019 report.
High-quality liquid assets
HQLA must be easily and immediately convertible into cash at little or no loss of value, especially during a period of stress. HQLA are assets that are of low risk and are unencumbered. Other characteristics of HQLA are ease and certainty of valuation, low correlation with risky assets, listing on a developed and recognized exchange, existence of an active and sizeable market, and low volatility. Based on these characteristics, HQLA are categorized as Level 1 (primarily central bank reserves and government bonds) or Level 2 (primarily US and European agency bonds, as well as non-financial corporate covered bonds). Level 2 assets are subject to regulatory haircuts and caps.
| High-quality liquid assets | ||||||
|---|---|---|---|---|---|---|
| Average 3Q19 1 | Average 2Q19 1 | |||||
| USD billion | Level 1 weighted liquidity value 2 | Level 2 weighted liquidity value 2 | Total weighted liquidity value 2 | Level 1 weighted liquidity value 2 | Level 2 weighted liquidity value 2 | Total weighted liquidity value 2 |
| Cash balances 3 | 99 | 0 | 99 | 108 | 0 | 108 |
| Securities (on- and off-balance sheet) | 53 | 16 | 69 | 53 | 15 | 68 |
| Total high-quality liquid | ||||||
| assets 4 | 152 | 16 | 168 | 161 | 15 | 176 |
| 1 Calculated based on an average of 66 data points in the third | ||||||
| quarter of 2019 and 65 data points in the second quarter of 2019. 2 | ||||||
| Calculated after the application of haircuts. 3 Includes cash and balances | ||||||
| with central banks and other eligible balances as prescribed by FINMA. 4 | ||||||
| Calculated in accordance with FINMA requirements. |
14
Liquidity coverage ratio
In the third quarter of 2019, the UBS Group liquidity coverage ratio (LCR) decreased 7 percentage points to 138%, remaining above the 110% Group LCR minimum communicated by the Swiss Financial Market Supervisory Authority (FINMA).
The LCR decrease was primarily driven by lower average high-quality liquid assets due to a reduction of cash at central banks reflecting higher average funding consumption by the business divisions and reductions in the level of issued debt.
| LIQ1: Liquidity coverage ratio | |||||
|---|---|---|---|---|---|
| Average 3Q19 1 | Average 2Q19 1 | ||||
| USD billion, except where | |||||
| indicated | Unweighted value | Weighted value 2 | Unweighted value | Weighted value 2 | |
| High-quality liquid assets | |||||
| 1 | High-quality liquid assets | 171 | 168 | 179 | 176 |
| Cash outflows | |||||
| 2 | Retail deposits and deposits from small business customers | 241 | 28 | 239 | 27 |
| 3 | of which: stable deposits | 31 | 1 | 31 | 1 |
| 4 | of which: less stable | ||||
| deposits | 210 | 27 | 207 | 26 | |
| 5 | Unsecured wholesale funding | 188 | 106 | 186 | 106 |
| 6 | of which: operational | ||||
| deposits (all counterparties) | 41 | 10 | 41 | 10 | |
| 7 | of which: non-operational | ||||
| deposits (all counterparties) | 135 | 83 | 132 | 82 | |
| 8 | of which: unsecured debt | 12 | 12 | 13 | 13 |
| 9 | Secured wholesale funding | 75 | 74 | ||
| 10 | Additional requirements: | 71 | 22 | 75 | 22 |
| 11 | of which: outflows related | ||||
| to derivatives and other transactions | 37 | 15 | 41 | 15 | |
| 12 | of which: outflows related | ||||
| to loss of funding on debt products 3 | 0 | 0 | 0 | 0 | |
| 13 | of which: committed credit | ||||
| and liquidity facilities | 34 | 7 | 34 | 7 | |
| 14 | Other contractual funding obligations | 14 | 12 | 14 | 12 |
| 15 | Other contingent funding obligations | 238 | 6 | 241 | 6 |
| 16 | Total cash outflows | 249 | 247 | ||
| Cash inflows | |||||
| 17 | Secured lending | 304 | 87 | 297 | 85 |
| 18 | Inflows from fully performing exposures | 62 | 28 | 65 | 29 |
| 19 | Other cash inflows | 12 | 12 | 11 | 11 |
| 20 | Total cash inflows | 379 | 127 | 373 | 126 |
| Average 3Q19 1 | Average 2Q19 1 | ||||
| USD billion, except where | |||||
| indicated | Total adjusted value 4 | Total adjusted value 4 | |||
| Liquidity coverage ratio | |||||
| 21 | High-quality liquid assets | 168 | 176 | ||
| 22 | Net cash outflows | 122 | 121 | ||
| 23 | Liquidity coverage ratio (%) | 138 | 145 | ||
| 1 Calculated based on an average of 66 data points in the third | |||||
| quarter of 2019 and 65 data points in the second quarter of 2019. 2 | |||||
| Calculated after the application of haircuts and inflow and outflow rates. | |||||
| 3 Includes outflows related to loss of funding on asset-backed | |||||
| securities, covered bonds, other structured financing instruments, | |||||
| asset-backed commercial papers, structured entities (conduits), securities | |||||
| investment vehicles and other such financing facilities. 4 Calculated | |||||
| after the application of haircuts and inflow and outflow rates as well as, | |||||
| where applicable, caps on Level 2 assets and cash inflows. |
15
Significant regulated subsidiaries and sub-groups
Significant regulated subsidiaries and sub-groups
Section 1 Introduction
The sections below include capital and other regulatory information for UBS AG standalone, UBS Switzerland AG standalone, UBS Europe SE consolidated and UBS Americas Holding LLC consolidated.
C apital information in this section is based on Pillar 1 requirements. Entities may be subject to significant additional Pillar 2 requirements, which represent additional amounts of capital considered necessary and agreed with regulators based on the risk profile of the entities.
Section 2 UBS AG standalone
Key metrics of the third quarter of 2019
The table below is based on Basel Committee on Banking Supervision (BCBS) Basel III phase-in rules. During the third quarter of 2019, common equity tier 1 (CET1) capital decreased by USD 0.8 billion to USD 50.5 billion, mainly due to accruals for capital returns and partly offset by operating profit. Risk-weighted assets (RWA) were stable during the quarter. Leverage ratio exposure decreased by USD 9 billion to USD 610 billion, mainly due to a decrease in on-balance sheet exposures (excluding derivative exposures and securities financing transactions). High-quality liquid assets decreased by USD 5.9 billion as a result of lower average cash balances, reflecting higher average funding consumption by the business divisions and reductions in the level of issued debt. Net cash outflows decreased by USD 1.0 billion, reflecting higher inflows from secured lending.
| KM1: Key metrics | ||||||
|---|---|---|---|---|---|---|
| USD million, except where | ||||||
| indicated | ||||||
| 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 | 30.9.18 4 | ||
| Available capital (amounts) 1 | ||||||
| 1 | Common equity tier 1 (CET1) | 50,458 | 51,261 | 49,024 | 49,411 | 49,810 |
| 1a | Fully loaded ECL accounting model | 50,456 | 51,258 | 49,021 | 49,411 | 49,810 |
| 2 | Tier 1 | 64,545 | 64,315 | 61,839 | 59,595 | 59,341 |
| 2a | Fully loaded ECL accounting model tier 1 | 64,543 | 64,312 | 61,836 | 59,595 | 59,341 |
| 3 | Total capital | 70,194 | 70,612 | 68,542 | 66,295 | 66,005 |
| 3a | Fully loaded ECL accounting model total capital | 70,191 | 70,609 | 68,539 | 66,295 | 66,005 |
| Risk-weighted assets | ||||||
| (amounts) | ||||||
| 4 | Total risk-weighted assets (RWA) | 297,200 | 294,348 | 300,734 | 292,888 | 288,045 |
| 4a | Minimum capital requirement 2 | 23,776 | 23,548 | 24,059 | 23,431 | 23,044 |
| 4b | Total risk-weighted assets (pre-floor) | 297,200 | 294,348 | 300,734 | 292,888 | 288,045 |
| Risk-based capital ratios as | ||||||
| a percentage of RWA 1 | ||||||
| 5 | Common equity tier 1 ratio (%) | 16.98 | 17.41 | 16.30 | 16.87 | 17.29 |
| 5a | Fully loaded ECL accounting model CET1 (%) | 16.98 | 17.41 | 16.30 | 16.87 | 17.29 |
| 6 | Tier 1 ratio (%) | 21.72 | 21.85 | 20.56 | 20.35 | 20.60 |
| 6a | Fully loaded ECL accounting model tier 1 ratio (%) | 21.72 | 21.85 | 20.56 | 20.35 | 20.60 |
| 7 | Total capital ratio (%) | 23.62 | 23.99 | 22.79 | 22.63 | 22.91 |
| 7a | Fully loaded ECL accounting model total capital ratio (%) | 23.62 | 23.99 | 22.79 | 22.63 | 22.91 |
| Additional CET1 buffer | ||||||
| requirements as a percentage of RWA | ||||||
| 8 | Capital conservation buffer requirement (2.5% from 2019) (%) | 2.50 | 2.50 | 2.50 | 1.88 | 1.88 |
| 9 | Countercyclical buffer requirement (%) | 0.08 | 0.08 | 0.09 | 0.07 | 0.05 |
| 9a | Additional countercyclical buffer for Swiss mortgage loans (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 10 | Bank G-SIB and / or D-SIB additional requirements (%) 3 | |||||
| 11 | Total of bank CET1 specific buffer requirements (%) 1 | 2.58 | 2.58 | 2.59 | 1.95 | 1.92 |
| 12 | CET1 available after meeting the bank’s minimum capital | |||||
| requirements (%) 1 | 12.48 | 12.91 | 11.80 | 12.37 | 12.79 | |
| Basel III leverage ratio | ||||||
| 13 | Total Basel III leverage ratio exposure measure | 609,656 | 618,704 | 617,329 | 601,013 | 619,741 |
| 14 | Basel III leverage ratio (%) 1 | 10.59 | 10.40 | 10.02 | 9.92 | 9.58 |
| 14a | Fully loaded ECL accounting model Basel III leverage ratio (%) 1 | 10.59 | 10.39 | 10.02 | 9.92 | 9.58 |
| Liquidity coverage ratio | ||||||
| 15 | Total HQLA | 76,330 | 82,201 | 86,690 | 76,456 | 81,214 |
| 16 | Total net cash outflow | 55,607 | 56,626 | 51,434 | 55,032 | 59,450 |
| 17 | LCR ratio (%) | 137 | 145 | 169 | 139 | 137 |
| 1 Based on BCBS Basel III phase-in rules. 2 Calculated as 8% | ||||||
| of total RWA, based on total capital minimum requirements, excluding CET1 | ||||||
| buffer requirements. 3 Swiss SRB going concern requirements and | ||||||
| information for UBS AG standalone is provided in the following pages in this | ||||||
| section. 4 In line with the change of the presentation currency of UBS | ||||||
| Group AG’s and UBS AG’s consolidated and standalone financial statements from | ||||||
| Swiss francs to US dollars in October 2018, prior periods were translated to | ||||||
| US dollars at the respective spot rates prevailing on the relevant reporting | ||||||
| dates. |
18
Swiss SRB going concern requirements and information
The table below provides details of the Swiss systematically relevant bank (SRB) risk-weighted assets (RWA)- and leverage ratio denominator (LRD)-based going concern requirements and information as required by FINMA.
| Swiss SRB going concern
requirements and information | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | Swiss SRB, including transitional arrangements | | | | Swiss SRB as of 1.1.20, after transition arrangements | | | |
| As of 30.9.19 | RWA | | LRD | | RWA | | LRD | |
| USD million, except where
indicated | in % 1 | | in % 1 | | in % | | in % | |
| Required going concern
capital | | | | | | | | |
| Total going concern capital | 14.38 2 | 42,747 | 5.00 2 | 30,483 | 14.38 2 | 55,055 | 5.00 2 | 30,483 |
| Common equity tier 1 capital | 10.08 | 29,968 | 3.50 | 21,338 | 10.08 | 38,596 | 3.50 | 21,338 |
| of which: minimum capital | 4.50 | 13,374 | 1.50 | 9,145 | 4.50 | 17,225 | 1.50 | 9,145 |
| of which: buffer capital | 5.50 | 16,346 | 2.00 | 12,193 | 5.50 | 21,052 | 2.00 | 12,193 |
| of which: countercyclical
buffer | 0.08 | 248 | | | 0.08 | 319 | | |
| Maximum additional tier 1
capital | 4.30 | 12,780 | 1.50 | 9,145 | 4.30 | 16,459 | 1.50 | 9,145 |
| of which: additional tier 1
capital | 3.50 | 10,402 | 1.50 | 9,145 | 3.50 | 13,397 | 1.50 | 9,145 |
| of which: additional tier 1
buffer capital | 0.80 | 2,378 | | | 0.80 | 3,062 | | |
| Eligible going concern
capital | | | | | | | | |
| Total going concern capital | 22.63 | 67,267 | 11.03 | 67,267 | 16.23 | 62,142 | 10.19 | 62,142 |
| Common equity tier 1 capital | 16.98 | 50,458 | 8.28 | 50,458 | 13.18 | 50,458 | 8.28 | 50,458 |
| Total loss-absorbing additional
tier 1 capital 3 | 5.66 | 16,809 | 2.76 | 16,809 | 3.05 | 11,684 | 1.92 | 11,684 |
| of which: high-trigger
loss-absorbing additional tier 1 capital | 3.93 | 11,684 | 1.92 | 11,684 | 3.05 | 11,684 | 1.92 | 11,684 |
| of which: low-trigger
loss-absorbing tier 2 capital | 1.72 | 5,125 | 0.84 | 5,125 | | | | |
| Risk-weighted assets /
leverage ratio denominator | | | | | | | | |
| Risk-weighted assets | 297,200 | | | | 382,770 | | | |
| Leverage ratio denominator | | | 609,656 | | | | 609,656 | |
| 1 By FINMA decree, requirements exceed those based on the
transitional arrangements of the Swiss Capital Adequacy Ordinance, i.e., a
total going concern capital ratio requirement of 13.58% plus the effect of
countercyclical buffer (CCyB) requirements of 0.08%, of which 9.68% plus the
effect of CCyB requirements of 0.08% must be satisfied with CET1 capital, and
a total going concern leverage ratio requirement of 4.5%, of which 3.2% must
be satisfied with CET1 capital. 2 Includes applicable add-ons of 1.44% for
RWA and 0.5% for LRD. 3 Includes outstanding low-trigger
loss-absorbing tier 2 capital instruments, which are available under the
transitional rules of the Swiss SRB framework to meet the going concern
requirements until the earlier of (i) their maturity or first call date or
(ii) 31 December 2019. Outstanding low-trigger loss-absorbing
tier 2 capital instruments are subject to amortization starting five years
prior to their maturity. | | | | | | | | |
19
Significant regulated subsidiaries and sub-groups
| Swiss SRB going concern information | ||||||
|---|---|---|---|---|---|---|
| Swiss SRB, including transitional arrangements | Swiss SRB as of 1.1.20, after transition arrangements | |||||
| USD million, except where | ||||||
| indicated | 30.9.19 | 30.6.19 | 31.12.18 | 30.9.19 | 30.6.19 | 31.12.18 |
| Eligible going concern | ||||||
| capital | ||||||
| Total going concern capital | 67,267 | 67,485 | 63,225 | 62,142 | 61,880 | 57,217 |
| Total tier 1 capital | 62,142 | 61,880 | 57,217 | 62,142 | 61,880 | 57,217 |
| Common equity tier 1 capital | 50,458 | 51,261 | 49,411 | 50,458 | 51,261 | 49,411 |
| Total loss-absorbing | ||||||
| additional tier 1 capital | 11,684 | 10,619 | 7,805 | 11,684 | 10,619 | 7,805 |
| of which: high-trigger | ||||||
| loss-absorbing additional tier 1 capital | 11,684 | 10,619 | 7,805 | 11,684 | 10,619 | 7,805 |
| Total tier 2 capital | 5,125 | 5,606 | 6,008 | |||
| of which: low-trigger | ||||||
| loss-absorbing tier 2 capital 1 | 5,125 | 5,606 | 6,008 | |||
| Risk-weighted assets / | ||||||
| leverage ratio denominator | ||||||
| Risk-weighted assets | 297,200 | 294,348 | 292,888 | 382,770 | 380,200 | 383,578 |
| of which: direct and | ||||||
| indirect investments in Swiss-domiciled subsidiaries 2 | 32,803 | 33,034 | 31,711 | 40,004 | 40,285 | 39,639 |
| of which: direct and | ||||||
| indirect investments in foreign-domiciled subsidiaries 2 | 95,784 | 96,068 | 82,762 | 174,153 | 174,668 | 165,525 |
| Leverage ratio denominator | 609,656 | 618,704 | 601,013 | 609,656 | 618,704 | 601,013 |
| Capital and loss-absorbing | ||||||
| capacity ratios (%) | ||||||
| Going concern capital ratio | 22.6 | 22.9 | 21.6 | 16.2 | 16.3 | 14.9 |
| of which: common equity tier | ||||||
| 1 capital ratio | 17.0 | 17.4 | 16.9 | 13.2 | 13.5 | 12.9 |
| Leverage ratios (%) | ||||||
| Going concern leverage ratio | 11.0 | 10.9 | 10.5 | 10.2 | 10.0 | 9.5 |
| of which: common equity tier | ||||||
| 1 leverage ratio | 8.3 | 8.3 | 8.2 | 8.3 | 8.3 | 8.2 |
| 1 Outstanding low-trigger loss-absorbing tier 2 capital | ||||||
| instruments qualify as going concern capital until the earlier of (i) their | ||||||
| maturity or first call date or (ii) 31 December 2019, and are subject to | ||||||
| amortization starting five years prior to their maturity. 2 Carrying | ||||||
| value for direct and indirect investments including holding of regulatory | ||||||
| capital instruments in Swiss-domiciled subsidiaries | ||||||
| (30 September 2019: USD 16,002 million; 30 June 2019: USD | ||||||
| 16,114 million), and for direct and indirect investments including holding of | ||||||
| regulatory capital instruments in foreign-domiciled subsidiaries | ||||||
| (30 September 2019: USD 43,538 million; | ||||||
| 30 June 2019: USD 43,667 million), is risk weighted at 205% | ||||||
| and 220%, respectively, for the current year. Risk weights will gradually increase | ||||||
| by 5% per year for Swiss-domiciled investments and 20% per year for | ||||||
| foreign-domiciled investments until the fully applied risk weights of 250% | ||||||
| and 400%, respectively, are applied. |
20
Leverage ratio information
| Swiss SRB leverage ratio
denominator — USD billion | 30.9.19 | 30.6.19 |
| --- | --- | --- |
| Leverage ratio denominator | | |
| Swiss GAAP total assets | 489.8 | 501.0 |
| Difference between Swiss GAAP and IFRS total assets | 136.5 | 121.6 |
| Less: derivative exposures and SFTs 1 | (250.4) | (238.9) |
| On-balance sheet exposures
(excluding derivative exposures and SFTs) | 376.0 | 383.7 |
| Derivative exposures | 102.2 | 100.5 |
| Securities financing transactions | 107.7 | 111.8 |
| Off-balance sheet items | 24.6 | 23.4 |
| Items deducted from Swiss SRB tier 1 capital | (0.9) | (0.6) |
| Total exposures (leverage
ratio denominator) | 609.7 | 618.7 |
| 1 Consists of derivative financial instruments, cash collateral
receivables on derivative instruments, receivables from securities financing
transactions, and margin loans, as well as prime brokerage receivables and
financial assets at fair value not held for trading, both related to
securities financing transactions, in accordance with the regulatory scope of
consolidation, which are presented separately under Derivative exposures and Securities
financing transactions in this table. | | |
| BCBS Basel III leverage ratio — USD million, except where
indicated | 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 |
| --- | --- | --- | --- | --- |
| Total tier 1 capital | 64,545 | 64,315 | 61,839 | 59,595 |
| Total exposures (leverage ratio denominator) | 609,656 | 618,704 | 617,329 | 601,013 |
| BCBS Basel III leverage
ratio (%) | 10.6 | 10.4 | 10.0 | 9.9 |
Liquidity coverage ratio
UBS AG is required to maintain a minimum liquidity coverage ratio of 105% as communicated by FINMA.
| Liquidity coverage ratio | ||
|---|---|---|
| Weighted value 1 | ||
| USD billion, except where | ||
| indicated | Average 3Q19 2 | Average 2Q19 2 |
| High-quality liquid assets | 76 | 82 |
| Total net cash outflows | 56 | 57 |
| of which: cash outflows | 177 | 175 |
| of which: cash inflows | 121 | 118 |
| Liquidity coverage ratio (%) | 137 | 145 |
| 1 Calculated after the application of haircuts and inflow and | ||
| outflow rates. 2 Calculated based on an average of 66 data points in the | ||
| third quarter of 2019 and 65 data points in the second quarter of 2019. |
21
Significant regulated subsidiaries and sub-groups
Section 3 UBS Switzerland AG standalone
Key metrics of the third quarter of 2019
The table below is based on Basel Committee on Banking Supervision (BCBS) Basel III phase-in rules. During the third quarter of 2019, common equity tier 1 (CET1) capital increased by CHF 0.2 billion to CHF 10.9 billion, mainly as a result of operating profit. Risk-weighted assets (RWA) increased by CHF 1.3 billion to CHF 97.9 billion, primarily due to an increase in the Basel I RWA floor. Leverage ratio exposure was stable during the quarter. High-quality liquid assets decreased by CHF 2.3 billion as a result of lower average cash balances, reflecting a decrease in average customer deposits.
| KM1: Key metrics | ||||||
|---|---|---|---|---|---|---|
| CHF million, except where | ||||||
| indicated | ||||||
| 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 | 30.9.18 | ||
| Available capital (amounts) 1 | ||||||
| 1 | Common equity tier 1 (CET1) | 10,875 | 10,654 | 10,463 | 10,225 | 10,165 |
| 1a | Fully loaded ECL accounting model | 10,871 | 10,649 | 10,457 | 10,225 | 10,165 |
| 2 | Tier 1 | 15,124 | 14,894 | 14,712 | 14,468 | 13,165 |
| 2a | Fully loaded ECL accounting model tier 1 | 15,120 | 14,889 | 14,706 | 14,468 | 13,165 |
| 3 | Total capital | 15,124 | 14,894 | 14,712 | 14,468 | 13,165 |
| 3a | Fully loaded ECL accounting model total capital | 15,120 | 14,889 | 14,706 | 14,468 | 13,165 |
| Risk-weighted assets | ||||||
| (amounts) | ||||||
| 4 | Total risk-weighted assets (RWA) | 97,927 | 96,640 | 96,067 | 95,646 | 95,541 |
| 4a | Minimum capital requirement 2 | 7,834 | 7,731 | 7,685 | 7,652 | 7,643 |
| 4b | Total risk-weighted assets (pre-floor) | 90,338 | 91,013 | 90,068 | 91,457 | 88,299 |
| Risk-based capital ratios as | ||||||
| a percentage of RWA 1 | ||||||
| 5 | Common equity tier 1 ratio (%) | 11.10 | 11.02 | 10.89 | 10.69 | 10.64 |
| 5a | Fully loaded ECL accounting model CET1 (%) | 11.10 | 11.02 | 10.89 | 10.69 | 10.64 |
| 6 | Tier 1 ratio (%) | 15.44 | 15.41 | 15.31 | 15.13 | 13.78 |
| 6a | Fully loaded ECL accounting model tier 1 ratio (%) | 15.44 | 15.41 | 15.31 | 15.13 | 13.78 |
| 7 | Total capital ratio (%) | 15.44 | 15.41 | 15.31 | 15.13 | 13.78 |
| 7a | Fully loaded ECL accounting model total capital ratio (%) | 15.44 | 15.41 | 15.31 | 15.13 | 13.78 |
| Additional CET1 buffer | ||||||
| requirements as a percentage of RWA 3 | ||||||
| 8 | Capital conservation buffer requirement (2.5% from 2019) (%) | 2.50 | 2.50 | 2.50 | 1.88 | 1.88 |
| 9 | Countercyclical buffer requirement (%) | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 |
| 9a | Additional countercyclical buffer for Swiss mortgage loans (%) | 0.57 | 0.57 | 0.58 | 0.56 | 0.56 |
| 10 | Bank G-SIB and / or D-SIB additional requirements (%) 4 | |||||
| 11 | Total of bank CET1 specific buffer requirements (%) 1 | 2.51 | 2.51 | 2.51 | 1.88 | 1.88 |
| 12 | CET1 available after meeting the bank’s minimum capital | |||||
| requirements (%) 1 | 6.60 | 6.52 | 6.39 | 6.19 | 6.14 | |
| Basel III leverage ratio | ||||||
| 13 | Total Basel III leverage ratio exposure measure | 309,750 | 311,212 | 310,545 | 306,487 | 303,257 |
| 14 | Basel III leverage ratio (%) 1 | 4.88 | 4.79 | 4.74 | 4.72 | 4.34 |
| 14a | Fully loaded ECL accounting model Basel III leverage ratio (%) 1 | 4.88 | 4.78 | 4.74 | 4.72 | 4.34 |
| Liquidity coverage ratio | ||||||
| 15 | Total HQLA | 64,835 | 67,160 | 71,392 | 67,427 | 66,174 |
| 16 | Total net cash outflow | 49,242 | 48,761 | 51,945 | 52,846 | 53,130 |
| 17 | LCR ratio (%) | 132 | 138 | 137 | 128 | 125 |
| 1 Based on BCBS Basel III phase-in rules. 2 Calculated as 8% | ||||||
| of total RWA, based on total capital minimum requirements, excluding CET1 | ||||||
| buffer requirements. 3 As Annex 8 of Swiss Capital Adequacy Ordinance | ||||||
| (CAO) does not apply to the systemically relevant banks, UBS can abstain from | ||||||
| disclosing the information required in lines 12a–12e. In the event of a waiver, | ||||||
| UBS nevertheless provides information about the Swiss sector-specific | ||||||
| countercyclical buffer in row 9a pursuant to Art. 44 CAO. 4 Swiss SRB | ||||||
| going concern requirements and information for UBS Switzerland AG are | ||||||
| provided on the next page. |
22
Swiss SRB going and gone concern requirements and information
UBS Switzerland AG is considered a systemically relevant bank (SRB) under Swiss banking law and is subject to capital regulations on a standalone basis . As of 30 September 2019, the transitional going concern capital and leverage ratio requirements for UBS Switzerland AG standalone were 14.16% and 4.5%, respectively. The gone concern requirements under transitional arrangements were 9.63% for the RWA-based requirement and 3.32% for the LRD-based requirement.
| Swiss SRB going and gone
concern requirements and information | | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| | Swiss SRB, including transitional arrangements | | | | Swiss SRB as of 1.1.20 | | | |
| As of 30.9.19 | RWA | | LRD | | RWA | | LRD | |
| CHF million, except where
indicated | in % 1 | | in % | | in % | | in % | |
| Required going concern
capital | | | | | | | | |
| Total going concern capital | 14.16 | 13,866 | 4.50 | 13,939 | 14.88 2 | 14,571 | 5.00 2 | 15,488 |
| Common equity tier 1 capital | 10.26 | 10,047 | 3.20 | 9,912 | 10.58 | 10,361 | 3.50 | 10,841 |
| of which: minimum capital | 4.90 | 4,798 | 1.70 | 5,266 | 4.50 | 4,407 | 1.50 | 4,646 |
| of which: buffer capital | 4.78 | 4,681 | 1.50 | 4,646 | 5.50 | 5,386 | 2.00 | 6,195 |
| of which: countercyclical
buffer | 0.58 | 568 | | | 0.58 | 568 | | |
| Maximum additional tier 1
capital | 3.90 | 3,819 | 1.30 | 4,027 | 4.30 | 4,211 | 1.50 | 4,646 |
| of which: additional tier 1
capital | 3.10 | 3,036 | 1.30 | 4,027 | 3.50 | 3,427 | 1.50 | 4,646 |
| of which: additional tier 1
buffer capital | 0.80 | 783 | | | 0.80 | 783 | | |
| Eligible going concern
capital | | | | | | | | |
| Total going concern capital | 15.44 | 15,124 | 4.88 | 15,124 | 15.44 | 15,124 | 4.88 | 15,124 |
| Common equity tier 1 capital | 11.10 | 10,875 | 3.51 | 10,875 | 11.10 | 10,875 | 3.51 | 10,875 |
| Total loss-absorbing
additional tier 1 capital | 4.34 | 4,249 | 1.37 | 4,249 | 4.34 | 4,249 | 1.37 | 4,249 |
| of which: high-trigger
loss-absorbing additional tier 1 capital | 4.34 | 4,249 | 1.37 | 4,249 | 4.34 | 4,249 | 1.37 | 4,249 |
| Required gone concern
capital | | | | | | | | |
| Total gone concern loss-absorbing
capacity | 9.63 | 9,428 | 3.32 | 10,284 | 11.87 | 11,623 | 4.15 | 12,855 |
| of which: base requirement | 10.52 | 10,302 | 3.63 | 11,228 | 12.86 | 12,593 | 4.50 | 13,939 |
| of which: additional
requirement for market share and LRD | 1.08 | 1,058 | 0.38 | 1,162 | 1.44 | 1,410 | 0.50 | 1,549 |
| of which: applicable
reduction on requirements | (1.97) | (1,931) | (0.68) | (2,106) | (2.43) | (2,381) | (0.85) | (2,633) |
| of which: rebate granted
(equivalent to 42.5% of maximum rebate) 3 | (1.97) | (1,931) | (0.68) | (2,106) | (2.43) | (2,381) | (0.85) | (2,633) |
| Eligible gone concern
capital | | | | | | | | |
| Total gone concern
loss-absorbing capacity | 11.18 | 10,948 | 3.53 | 10,948 | 11.18 | 10,948 | 3.53 | 10,948 |
| TLAC-eligible debt | 11.18 | 10,948 | 3.53 | 10,948 | 11.18 | 10,948 | 3.53 | 10,948 |
| Total loss-absorbing
capacity | | | | | | | | |
| Required total
loss-absorbing capacity | 23.79 | 23,295 | 7.82 | 24,222 | 26.75 | 26,194 | 9.15 | 28,342 |
| Eligible total
loss-absorbing capacity | 26.62 | 26,072 | 8.42 | 26,072 | 26.62 | 26,072 | 8.42 | 26,072 |
| Risk-weighted assets /
leverage ratio denominator | | | | | | | | |
| Risk-weighted assets | 97,927 | | | | 97,927 | | | |
| Leverage ratio denominator | | | 309,750 | | | | 309,750 | |
| 1 The total loss-absorbing capacity ratio requirement of 23.79%
is the current requirement based on the transitional rules of the Swiss
Capital Adequacy Ordinance including the aforementioned rebate on the gone
concern requirements. In addition, FINMA has defined a total capital ratio
requirement, which is the sum of 14.4% and the effect of countercyclical
buffer (CCyB) requirements of 0.58%, of which 10% plus the effect of CCyB
requirements must be satisfied with CET1 capital. These FINMA requirements
will be effective until they are exceeded by the Swiss SRB requirements based
on the transitional rules. 2 Includes applicable add-ons of 1.44% for RWA
and 0.5% for LRD. 3 Based on the actions we completed up to December 2018
to improve resolvability, FINMA granted a rebate on the gone concern
requirement of 42.5% of the maximum rebate in the third quarter of 2019 as
compared with 40% in the previous quarter. | | | | | | | | |
23
Significant regulated subsidiaries and sub-groups
Swiss SRB loss-absorbing capacity
| Swiss SRB going and gone
concern information 1 — CHF million, except where
indicated | 30.9.19 | 30.6.19 | 31.12.18 |
| --- | --- | --- | --- |
| Eligible going concern
capital | | | |
| Total going concern capital | 15,124 | 14,894 | 14,468 |
| Total tier 1 capital | 15,124 | 14,894 | 14,468 |
| Common equity tier 1 capital | 10,875 | 10,654 | 10,225 |
| of which: high-trigger
loss-absorbing additional tier 1 capital | 4,249 | 4,240 | 4,243 |
| Eligible gone concern
capital | | | |
| Total gone concern
loss-absorbing capacity | 10,948 | 10,924 | 10,932 |
| TLAC-eligible debt | 10,948 | 10,924 | 10,932 |
| Total loss-absorbing
capacity | | | |
| Total loss-absorbing
capacity | 26,072 | 25,818 | 25,400 |
| Risk-weighted assets /
leverage ratio denominator | | | |
| Risk-weighted assets | 97,927 | 96,640 | 95,646 |
| Leverage ratio denominator | 309,750 | 311,212 | 306,487 |
| Capital and loss-absorbing
capacity ratios (%) | | | |
| Going concern capital ratio | 15.4 | 15.4 | 15.1 |
| of which: common equity tier
1 capital ratio | 11.1 | 11.0 | 10.7 |
| Gone concern loss-absorbing capacity ratio | 11.2 | 11.3 | 11.4 |
| Total loss-absorbing
capacity ratio | 26.6 | 26.7 | 26.6 |
| Leverage ratios (%) | | | |
| Going concern leverage ratio | 4.9 | 4.8 | 4.7 |
| of which: common equity tier
1 leverage ratio | 3.5 | 3.4 | 3.3 |
| Gone concern leverage ratio | 3.5 | 3.5 | 3.6 |
| Total loss-absorbing
capacity leverage ratio | 8.4 | 8.3 | 8.3 |
| 1 The numbers disclosed in the table are identical for Swiss SRB
(including transitional arrangement) requirements and Swiss SRB requirements
applicable as of 1 January 2020. | | | |
24
Leverage ratio information
| Swiss SRB leverage ratio
denominator — CHF billion | 30.9.19 | 30.6.19 |
| --- | --- | --- |
| Leverage ratio denominator | | |
| Swiss GAAP total assets | 294.2 | 295.7 |
| Difference between Swiss GAAP and IFRS total assets | 5.3 | 3.6 |
| Less: derivative exposures and SFTs 1 | (31.9) | (39.2) |
| On-balance sheet exposures
(excluding derivative exposures and SFTs) | 267.6 | 260.1 |
| Derivative exposures | 5.1 | 5.0 |
| Securities financing transactions | 26.3 | 34.3 |
| Off-balance sheet items | 12.0 | 12.0 |
| Items deducted from Swiss SRB tier 1 capital | (1.3) | (0.2) |
| Total exposures (leverage
ratio denominator) | 309.8 | 311.2 |
| 1 Consists of derivative financial instruments, cash collateral
receivables on derivative instruments, receivables from securities financing
transactions, and margin loans as well as prime brokerage receivables and
financial assets at fair value not held for trading, both related to
securities financing transactions, in accordance with the regulatory scope of
consolidation, which are presented separately under Derivative exposures and
Securities financing transactions in this table. | | |
| BCBS Basel III leverage ratio — CHF million, except where
indicated | 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 |
| --- | --- | --- | --- | --- |
| Total tier 1 capital | 15,124 | 14,894 | 14,712 | 14,468 |
| Total exposures (leverage ratio denominator) | 309,750 | 311,212 | 310,545 | 306,487 |
| BCBS Basel III leverage ratio
(%) | 4.9 | 4.8 | 4.7 | 4.7 |
Liquidity coverage ratio
UBS Switzerland AG, as a Swiss SRB, is required to maintain a minimum liquidity coverage ratio of 100%.
| Liquidity coverage ratio | ||
|---|---|---|
| Weighted value 1 | ||
| CHF billion, except where | ||
| indicated | Average 3Q19 2 | Average 2Q19 2 |
| High-quality liquid assets | 65 | 67 |
| Total net cash outflows | 49 | 49 |
| of which: cash outflows | 84 | 85 |
| of which: cash inflows | 35 | 36 |
| Liquidity coverage ratio (%) | 132 | 138 |
| 1 Calculated after the application of haircuts and inflow and | ||
| outflow rates. 2 Calculated based on an average of 66 data points in the | ||
| third quarter of 2019 and 65 data points in the second quarter of 2019. |
25
Significant regulated subsidiaries and sub-groups
Capital instruments
| Capital instruments of UBS
Switzerland AG – key features | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Presented according to issuance date. | | | | | | | |
| | | Share capital | Additional tier 1 capital | | | | |
| 1 | Issuer | UBS Switzerland AG, Switzerland | UBS Switzerland AG, Switzerland | | | | |
| 1a | Instrument number | 1 | 2 | 3 | 4 | 5 | 6 |
| 2 | Unique identifier (e.g., CUSIP, ISIN or Bloomberg identifier for
private placement) | n/a | n/a | | | | |
| 3 | Governing law(s) of the instrument | Swiss | Swiss | | | | |
| 3a | Means by which enforceability requirement of Section 13 of the
TLAC Term Sheet is achieved (for other TLAC-eligible instruments governed by
foreign law) | n/a | n/a | | | | |
| | Regulatory treatment | | | | | | |
| 4 | Transitional Basel III rules 1 | CET1 – Going concern capital | Additional tier 1 capital | | | | |
| 5 | Post-transitional Basel III rules 2 | CET1 – Going concern capital | Additional tier 1 capital | | | | |
| 6 | Eligible at solo / group / group and solo | UBS Switzerland AG consolidated and standalone | UBS Switzerland AG consolidated and standalone | | | | |
| 7 | Instrument type (types to be specified by each jurisdiction) | Ordinary shares | Loan 4 | Loan 4 | Loan 4 | Loan | Loan |
| 8 | Amount recognized in regulatory capital (currency in millions,
as of most recent reporting date) 1 | CHF 10.0 | CHF 1,500 | CHF 500 | CHF 1,000 | CHF 825 | USD 425 |
| 9 | Par value of instrument | CHF 10.0 | CHF 1,500 | CHF 500 | CHF 1,000 | CHF 825 | USD 425 |
| 10 | Accounting classification 3 | Equity attributable to UBS Switzerland AG shareholders | Due to banks held at amortized cost | | | | |
| 11 | Original date of issuance | – | 1 April 2015 | 11 March 2016 | 18 December 2017 | 12 December 2018 | 12 December 2018 |
| 12 | Perpetual or dated | – | Perpetual | | | | |
| 13 | Original maturity date | – | – | | | | |
| 14 | Issuer call subject to prior supervisory approval | – | Yes | | | | |
| 15 | Optional call date, contingent call dates and redemption amount | – | First optional repayment date: 1 April 2020 | First optional repayment date: 11 March 2021 | First optional repayment date: 18 December 2022 | First optional repayment date: 12 December 2023 | First optional repayment date: 12 December 2023 |
| | | | Repayable at any time after the first optional repayment date. Repayment subject to FINMA approval. Optional repayment amount:
principal amount, together with any accrued and unpaid interest thereon | | | | |
| 16 | Subsequent call dates, if applicable | – | Early repayment possible due to a tax or regulatory event.
Repayment due to tax event subject to FINMA approval. Repayment amount: principal amount, together with accrued and
unpaid interest | | | | |
26
| Capital instruments of UBS Switzerland AG – key features
(continued) | | | | | | | |
| --- | --- | --- | --- | --- | --- | --- | --- |
| | Coupons | | | | | | |
| 17 | Fixed or floating dividend / coupon | – | Floating | | | | |
| 18 | Coupon rate and any related index | – | 6-month CHF Libor + 370 bps per annum semiannually | 3-month CHF Libor + 459 bps per annum quarterly | 3-month CHF Libor + 250 bps per annum quarterly | 3-month CHF Libor + 489 bps per annum quarterly | 3-month USD Libor + 547 bps per annum quarterly |
| 19 | Existence of a dividend stopper | – | No | | | | |
| 20 | Fully discretionary, partially discretionary or mandatory | Fully discretionary | Fully discretionary | | | | |
| 21 | Existence of step-up or other incentive to redeem | – | No | | | | |
| 22 | Non-cumulative or cumulative | Non-cumulative | Non-cumulative | | | | |
| 23 | Convertible or non-convertible | – | Non-convertible | | | | |
| 24 | If convertible, conversion trigger(s) | – | – | | | | |
| 25 | If convertible, fully or partially | – | – | | | | |
| 26 | If convertible, conversion rate | – | – | | | | |
| 27 | If convertible, mandatory or optional conversion | – | – | | | | |
| 28 | If convertible, specify instrument type convertible into | – | – | | | | |
| 29 | If convertible, specify issuer of instrument it converts into | – | – | | | | |
| 30 | Write-down feature | – | Yes | | | | |
| 31 | If write-down, write-down trigger(s) | – | Trigger: CET1 ratio is less than 7% | | | | |
| | | | FINMA determines a write-down necessary to ensure UBS
Switzerland AG’s viability; or UBS Switzerland AG receives a commitment of
governmental support that FINMA determines necessary to ensure UBS
Switzerland AG‘s viability. Subject to applicable conditions | | | | |
| 32 | If write-down, fully or partially | – | Fully | | | | |
| 33 | If write-down, permanent or temporary | – | Permanent | | | | |
| 34 | If temporary write-down, description of write-up mechanism | – | – | | | | |
| 34a | Type of subordination | Statutory | Contractual | | | | |
| 35 | Position in subordination hierarchy in liquidation (specify
instrument type immediately senior to instrument in the insolvency creditor hierarchy of the
legal entity concerned). | Unless otherwise stated in the articles of association, once
debts are paid back, the assets of the liquidated company are divided between
the shareholders pro rata based on their contributions and considering the
preferences attached to certain categories of shares (Art. 745, Swiss
Code of Obligations) | Subject to any obligations that are mandatorily preferred by law,
all obligations of UBS Switzerland AG that are unsubordinated or that are
subordinated and do not rank junior, such as all classes of share capital, or
at par, such as tier 1 instruments | | | | |
| 36 | Non-compliant transitioned features | – | – | | | | |
| 37 | If yes, specify non-compliant features | – | – | | | | |
| 1 Based on Swiss SRB (including transitional arrangement)
requirements. 2 Based on Swiss SRB requirements applicable as of 1 January
2020. 3 As applied in UBS Switzerland AG‘s financial statements under
Swiss GAAP. 4 Loans granted by UBS AG, Switzerland. | | | | | | | |
27
Significant regulated subsidiaries and sub-groups
Section 4 UBS Europe SE consolidated
The table below discloses information about the regulatory capital components, capital ratios, leverage ratio and liquidity of UBS Europe SE consolidated based on the Pillar 1 requirements.
During the third quarter of 2019, common equity tier 1 (CET1) capital was stable. Risk-weighted assets (RWA) increased by EUR 0.7 billion, mainly as a result of an increase in credit risk RWA. Leverage ratio exposure decreased by EUR 2.1 billion, reflecting a decrease in securities financing transactions, partly offset by an increase in high-quality liquid asset (HQLA)-eligible bonds. Net cash outflows increased by EUR 0.9 billion, mainly due to clearing and treasury activities.
Entities may also be subject to significant Pillar 2 requirements, which represent additional amounts of capital considered necessary and agreed with regulators based on the risk profile of the entities.
| KM1: Key metrics 1,2,3 | ||||
|---|---|---|---|---|
| EUR million, except where | ||||
| indicated | ||||
| 30.9.19 | 30.6.19 | 31.3.19 | ||
| Available capital (amounts) | ||||
| 1 | Common equity tier 1 (CET1) | 3,528 | 3,543 | 3,568 |
| 2 | Tier 1 | 3,818 | 3,833 | 3,858 |
| 3 | Total capital | 3,818 | 3,833 | 3,858 |
| Risk-weighted assets | ||||
| (amounts) | ||||
| 4 | Total risk-weighted assets (RWA) | 14,407 | 13,725 | 14,432 |
| 4a | Minimum capital requirement 4 | 1,153 | 1,098 | 1,155 |
| Risk-based capital ratios as | ||||
| a percentage of RWA | ||||
| 5 | Common equity tier 1 ratio (%) | 24.5 | 25.8 | 24.7 |
| 6 | Tier 1 ratio (%) | 26.5 | 27.9 | 26.7 |
| 7 | Total capital ratio (%) | 26.5 | 27.9 | 26.7 |
| Additional CET1 buffer | ||||
| requirements as a percentage of RWA | ||||
| 8 | Capital conservation buffer requirement (2.5% from 2019) (%) | 2.5 | 2.5 | 2.5 |
| 9 | Countercyclical buffer requirement (%) | 0.3 | 0.2 | 0.2 |
| 10 | Bank G-SIB and / or D-SIB additional requirements (%) | |||
| 11 | Total of bank CET1 specific buffer requirements (%) | 2.8 | 2.7 | 2.7 |
| 12 | CET1 available after meeting the bank’s minimum capital | |||
| requirements (%) 5 | 18.5 | 19.9 | 18.7 | |
| Basel III leverage ratio | ||||
| 13 | Total Basel III leverage ratio exposure measure | 50,199 | 52,291 | 51,060 |
| 14 | Basel III leverage ratio (%) 6 | 7.6 | 7.3 | 7.6 |
| Liquidity coverage ratio 7 | ||||
| 15 | Total HQLA | 14,309 | 14,367 | 14,770 |
| 16 | Total net cash outflow | 9,091 | 8,200 | 6,895 |
| 17 | LCR ratio (%) | 161 | 177 | 214 |
| 1 Based on applicable EU Basel III rules. 2 As a result of | ||||
| the cross-border merger of UBS Limited into UBS Europe SE effective 1 March | ||||
| 2019, UBS Europe SE has become a significant regulated subsidiary of UBS | ||||
| Group AG. The size, scope and business model of the merged entity is now | ||||
| materially different. Comparatives for December 2018 have not been provided | ||||
| in the table because data produced on the same basis is not available. For | ||||
| more information about the cross-border merger of UBS Limited into UBS Europe | ||||
| SE, refer to the “Recent developments” section in our first quarter 2019 | ||||
| report. 3 There is no local disclosure requirement for the net stable | ||||
| funding ratio as at 30 September 2019. 4 Calculated as 8% of total | ||||
| RWA, based on total capital minimum requirements, excluding CET1 buffer | ||||
| requirements. 5 This represents the CET1 ratio which is available for | ||||
| meeting buffer requirements. It is calculated as the CET1 ratio minus 4.5% | ||||
| and after considering, where applicable, CET1 capital which has been used to | ||||
| meet tier 1 and / or total capital ratio requirements. Comparative figures | ||||
| have been adjusted to adhere to this presentation. 6 On the basis of tier | ||||
| 1 capital. 7 Figures as of 30 September 2019 are based on a | ||||
| seven-month average and as of 30 June 2019 on a four-month average, | ||||
| rather than a twelve-month average, as data produced on the same basis is | ||||
| only available for the period since the cross-border merger. For | ||||
| 31 March 2019, month-end reporting date values are disclosed. |
28
Section 5 UBS Americas Holding LLC consolidated
The table below discloses information about the regulatory capital components and capital ratios, as well as the leverage ratio, of UBS Americas Holding LLC consolidated based on the Pillar 1 requirements (i.e., US Basel III standardized rules).
During the third quarter of 2019, common equity tier 1 (CET1) decreased by USD 1.0 billion to USD 11.9 billion, mainly as a result of purchases of common shares, partly offset by operating profit. Risk-weighted assets (RWA) decreased by USD 0.9 billion to USD 52.9 billion, mainly driven by a decrease in credit risk RWA. Leverage ratio exposure was stable during the quarter.
Entities may also be subject to significant Pillar 2 requirements, which represent additional amounts of capital considered necessary and agreed with regulators based on the risk profile of the entities.
| KM1: Key metrics 1,2 | ||||||
|---|---|---|---|---|---|---|
| USD million, except where | ||||||
| indicated | ||||||
| 30.9.19 | 30.6.19 | 31.3.19 | 31.12.18 3 | 30.9.18 4 | ||
| Available capital (amounts) | ||||||
| 1 | Common equity tier 1 (CET1) | 11,868 | 12,900 | 12,028 | 11,746 | 11,068 |
| 2 | Tier 1 | 14,923 | 15,055 | 14,170 | 13,887 | 13,209 |
| 3 | Total capital | 15,640 | 15,772 | 14,882 | 14,601 | 13,925 |
| Risk-weighted assets | ||||||
| (amounts) | ||||||
| 4 | Total risk-weighted assets (RWA) | 52,947 | 53,892 | 55,313 | 54,063 | 54,488 |
| 4a | Minimum capital requirement 5 | 4,236 | 4,311 | 4,425 | 4,325 | 4,359 |
| Risk-based capital ratios as | ||||||
| a percentage of RWA | ||||||
| 5 | Common equity tier 1 ratio (%) | 22.4 | 23.9 | 21.7 | 21.7 | 20.3 |
| 6 | Tier 1 ratio (%) | 28.2 | 27.9 | 25.6 | 25.7 | 24.2 |
| 7 | Total capital ratio (%) | 29.5 | 29.3 | 26.9 | 27.0 | 25.6 |
| Additional CET1 buffer | ||||||
| requirements as a percentage of RWA | ||||||
| 8 | Capital conservation buffer requirement (2.5% from 2019) (%) | 2.5 | 2.5 | 2.5 | 1.9 | 1.9 |
| 9 | Countercyclical buffer requirement (%) 6 | |||||
| 10 | Bank G-SIB and / or D-SIB additional requirements (%) 7 | |||||
| 11 | Total of bank CET1 specific buffer requirements (%) | 2.5 | 2.5 | 2.5 | 1.9 | 1.9 |
| 12 | CET1 available after meeting the bank’s minimum capital | |||||
| requirements (%) 8 | 17.9 | 19.4 | 17.2 | 17.2 | 15.8 | |
| Basel III leverage ratio | ||||||
| 13 | Total Basel III leverage ratio exposure measure | 123,632 | 123,008 | 124,981 | 122,829 | 124,982 |
| 14 | Basel III leverage ratio (%) 9 | 12.1 | 12.2 | 11.3 | 11.3 | 10.6 |
| 1 For UBS Americas Holding LLC based on applicable US Basel III | ||||||
| rules. 2 There is no local disclosure requirement for liquidity coverage ratio | ||||||
| or net stable funding ratio for UBS Americas Holding LLC as of | ||||||
| 30 September 2019. 3 Figures as of or for the quarter ended 31 | ||||||
| December 2018 have been adjusted for consistency with the full-year audited | ||||||
| financial statements and / or local regulatory reporting, which were | ||||||
| finalized after the publication of our Annual Report 2018 and our 31 December | ||||||
| 2018 Pillar 3 report on 15 March 2019. 4 Figures as of 30 September 2018 | ||||||
| have been adjusted for consistency with the local regulatory reporting of the | ||||||
| entity. 5 Calculated as 8% of total RWA, based on total capital minimum | ||||||
| requirements, excluding CET1 buffer requirements. 6 Not applicable as the | ||||||
| countercyclical buffer requirement applies only to banking organizations | ||||||
| subject to the advanced approaches capital rules. 7 Not applicable as | ||||||
| requirements have not been proposed. 8 This represents the CET1 ratio | ||||||
| which is available for meeting buffer requirements. It is calculated as the | ||||||
| CET1 ratio minus 4.5% and after considering, where applicable, CET1 capital | ||||||
| which has been used to meet tier 1 and / or total capital ratio requirements. | ||||||
| Comparative figures have been adjusted to adhere to this presentation. 9 | ||||||
| On the basis of tier 1 capital. |
29
Appendix
Abbreviations frequently used in our financial reports
A
ABS asset-backed security
AEI automatic exchange of information
AGM annual general meeting of shareholders
A-IRB advanced internal ratings-based
AI artificial intelligence
AIV alternative investment vehicle
ALCO Asset and Liability Management Committee
AMA advanced measurement approach
AML anti-money laundering
AoA Articles of Association of UBS Group AG
ASF available stable funding
ASFA advanced supervisory formula approach
AT1 additional tier 1
AuM assets under management
B
BCBS Basel Committee on Banking Supervision
BD business division
BEAT base erosion and anti-abuse tax
BIS Bank for International Settlements
BoD Board of Directors
BSC Business Solutions Center
BVG Swiss occupational pension plan
C
CAO Capital Adequacy Ordinance
CC Corporate Center
CCAR Comprehensive Capital Analysis and Review
CCyB countercyclical buffer
CCF credit conversion factor
CCP central counterparty
CCR counterparty credit risk
CCRC Corporate Culture and Responsibility Committee
CDO collateralized debt obligation
CDR constant default rate
CDS credit default swap
CEA Commodity Exchange Act
CECL current expected credit loss
CEM current exposure method
CEO Chief Executive Officer
CET1 common equity tier 1
CFO Chief Financial Officer
CFTC US Commodity Futures Trading Commission
CHF Swiss franc
CIC Corporate Institutional Clients
CIO Chief Investment Office
CLN credit-linked note
CLO collateralized loan obligation
CLS continuous linked settlement
CMBS commercial mortgage-backed security
C&ORC Compliance & Operational Risk Control
CRD IV EU Capital Requirements Directive of 2013
CRM credit risk mitigation (credit risk) or comprehensive risk measure (market risk)
CSO Client Strategy Office
CVA credit valuation adjustment
D
DBO defined benefit obligation
DCCP Deferred Contingent Capital Plan
DJSI Dow Jones Sustainability Indices
DOJ US Department of Justice
DOL US Department of Labor
D-SIB domestic systemically important bank
DTA deferred tax asset
DVA debit valuation adjustment
E
EAD exposure at default
EBA European Banking Authority
EC European Commission
ECB European Central Bank
ECL expected credit loss(es)
EIR effective interest rate
EL expected loss
EMEA Europe, Middle East and Africa
EOP Equity Ownership Plan
EPE expected positive exposure
EPS earnings per share
ERISA Employee Retirement Income Security Act of 1974
ESG environmental, social and governance
ESMA European Securities and Markets Authority
ESR environmental and social risk
ETD exchange-traded derivative
ETF exchange-traded fund
EU European Union
EUR euro
EURIBOR Euro Interbank Offered Rate
F
FCA UK Financial Conduct Authority
FCT foreign currency translation
FINMA Swiss Financial Market Supervisory Authority
FINRA US Financial Industry Regulatory Authority
FMIA Swiss Financial Market Infrastructure Act
30
Abbreviations frequently used in our financial reports (continued)
FRA forward rate agreement
FSB Financial Stability Board
FTA Swiss Federal Tax Administration
FTD first to default
FTP funds transfer pricing
FVA funding valuation adjustment
FVOCI fair value through other comprehensive income
FVTPL fair value through profit or loss
FX foreign exchange
G
GAAP generally accepted accounting principles
GBP pound sterling
GEB Group Executive Board
GFA Group Franchise Awards
GHG greenhouse gas
GIA Group Internal Audit
GIIPS Greece, Italy, Ireland, Portugal and Spain
GMD Group Managing Director
GRI Global Reporting Initiative
Group ALM Group Asset and Liability Management
G-SIB global systemically important bank
H
HQLA high-quality liquid assets
HR human resources
I
IAA internal assessment approach
IAS International Accounting Standards
IASB International Accounting Standards Board
IBOR interbank offered rate
IFRIC International Financial Reporting Interpretations Committee
IFRS International Financial Reporting Standards
IHC intermediate holding company
IMA internal models approach
IMM internal model method
IPS Investment Platforms and Solutions
IRB internal ratings-based
IRC incremental risk charge
IRRBB interest rate risk in the banking book
ISDA International Swaps and Derivatives Association
K
KRT Key Risk Taker
L
LAC loss-absorbing capacity
LAS liquidity-adjusted stress
LCR liquidity coverage ratio
LGD loss given default
LIBOR London Interbank Offered Rate
LLC limited liability company
LRD leverage ratio denominator
LTV loan-to-value
M
MiFID II Markets in Financial Instruments Directive II
MiFIR Markets in Financial Instruments Regulation
MRT Material Risk Taker
MTN medium-term note
N
NAV net asset value
NII net interest income
NRV negative replacement value
NSFR net stable funding ratio
NYSE New York Stock Exchange
O
OCA own credit adjustment
OCI other comprehensive income
OECD Organisation for Economic Co-operation and Development
OIS overnight index swap
OTC over-the-counter
P
PD probability of default
PFE potential future exposure
PIT point in time
P&L profit or loss
POCI purchased or originated credit-impaired
PRA UK Prudential Regulation Authority
PRV positive replacement value
Q
QRRE qualifying revolving retail exposures
R
RBA role-based allowances
RBC risk-based capital
RLN reference-linked note
RMBS residential mortgage-backed securities
RniV risks not in VaR
RoAE return on attributed equity
RoCET1 return on CET1
RoE return on equity
RoTE return on tangible equity
RoU right-of-use
RV replacement value
RW risk weight
RWA risk-weighted assets
31
Appendix
Abbreviations frequently used in our financial reports (continued)
S
SA standardized approach
SA-CCR standardized approach for counterparty credit risk
SAR stock appreciation right
SBC Swiss Bank Corporation
SCCL single-counterparty credit limit
SDGs Sustainable Development Goals
SE structured entity
SEC US Securities and Exchange Commission
SEEOP Senior Executive Equity Ownership Plan
SFTs securities financing transactions
SI sustainable investing
SICR significant increase in credit risk
SIX SIX Swiss Exchange
SMA standardized measurement approach
SME small and medium-sized enterprises
SMF Senior Management Function
SNB Swiss National Bank
SPPI solely payments of principal and interest
SRB systemically relevant bank
SRM specific risk measure
SVaR stressed value-at-risk
T
TBTF too big to fail
TCJA US Tax Cuts and Jobs Act
TLAC total loss-absorbing capacity
TRS total return swap
TTC through the cycle
U
UoM units of measure
USD US dollar
US IHC US intermediate holding company
V
VaR value-at-risk
This is a general list of the abbreviations frequently used in our financial reporting. Not all of the listed abbreviations may appear in this particular report.
32
Cautionary Statement | This report and the information contained herein are provided solely for information purposes, and are not to be construed as solicitation of an offer to buy or sell any securities or other financial instruments in Switzerland, the United States or any other jurisdiction. No investment decision relating to securities of or relating to UBS Group AG, UBS AG or their affiliates should be made on the basis of this report. Refer to UBS’s third quarter 2019 report and its Annual Report 2018, available at www.ubs.com/investors , for additional information.
Rounding | Numbers presented throughout this report may not add up precisely to the totals provided in the tables and text. Percentages, percent changes, and adjusted results are calculated on the basis of unrounded figures. Information about absolute changes between reporting periods, which is provided in text and that can be derived from figures displayed in the tables, is calculated on a rounded basis.
Tables | Within tables, blank fields generally indicate that the field is not applicable or not meaningful, or that information is not available as of the relevant date or for the relevant period. Zero values generally indicate that the respective figure is zero on an actual or rounded basis. Percentage changes are presented as a mathematical calculation of the change between periods.
33
UBS Group AG
P.O. Box
CH-8098 Zurich
ubs.com
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned, thereunto duly authorized.
UBS Group AG
By: _/s/ David Kelly_______
Name: David Kelly
Title: Managing Director
By: _/s/ Ella Campi _____
Name: Ella Campi
Title: Executive Director
UBS AG
By: _/s/ David Kelly_______
Name: David Kelly
Title: Managing Director
By: _/s/ Ella Campi _____
Name: Ella Campi
Title: Executive Director
Date: October 22, 2019